Cargando…
Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19
The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment wil...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813092/ https://www.ncbi.nlm.nih.gov/pubmed/33489151 http://dx.doi.org/10.1002/ccr3.3487 |
| _version_ | 1783637790046552064 |
|---|---|
| author | Khatib, Mohamad Y. Shaik, Karimulla S. Ahmed, Amna A. Alwraidat, Mohammad A. Mohamed, Ahmed S. Abou Kamar, Mohamad R. Sharaf Eldean, Mouhammad Z. Aldaraiseh, Bashar K. Nashwan, Abdulqadir J. |
| author_facet | Khatib, Mohamad Y. Shaik, Karimulla S. Ahmed, Amna A. Alwraidat, Mohammad A. Mohamed, Ahmed S. Abou Kamar, Mohamad R. Sharaf Eldean, Mouhammad Z. Aldaraiseh, Bashar K. Nashwan, Abdulqadir J. |
| author_sort | Khatib, Mohamad Y. |
| collection | PubMed |
| description | The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment will prevent life‐threatening bleeding and mortality. |
| format | Online Article Text |
| id | pubmed-7813092 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78130922021-01-22 Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19 Khatib, Mohamad Y. Shaik, Karimulla S. Ahmed, Amna A. Alwraidat, Mohammad A. Mohamed, Ahmed S. Abou Kamar, Mohamad R. Sharaf Eldean, Mouhammad Z. Aldaraiseh, Bashar K. Nashwan, Abdulqadir J. Clin Case Rep Case Reports The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment will prevent life‐threatening bleeding and mortality. John Wiley and Sons Inc. 2020-11-12 /pmc/articles/PMC7813092/ /pubmed/33489151 http://dx.doi.org/10.1002/ccr3.3487 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Case Reports Khatib, Mohamad Y. Shaik, Karimulla S. Ahmed, Amna A. Alwraidat, Mohammad A. Mohamed, Ahmed S. Abou Kamar, Mohamad R. Sharaf Eldean, Mouhammad Z. Aldaraiseh, Bashar K. Nashwan, Abdulqadir J. Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19 |
| title | Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19 |
| title_full | Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19 |
| title_fullStr | Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19 |
| title_full_unstemmed | Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19 |
| title_short | Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19 |
| title_sort | tocilizumab‐induced cytomegalovirus colitis in a patient with covid‐19 |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813092/ https://www.ncbi.nlm.nih.gov/pubmed/33489151 http://dx.doi.org/10.1002/ccr3.3487 |
| work_keys_str_mv | AT khatibmohamady tocilizumabinducedcytomegaloviruscolitisinapatientwithcovid19 AT shaikkarimullas tocilizumabinducedcytomegaloviruscolitisinapatientwithcovid19 AT ahmedamnaa tocilizumabinducedcytomegaloviruscolitisinapatientwithcovid19 AT alwraidatmohammada tocilizumabinducedcytomegaloviruscolitisinapatientwithcovid19 AT mohamedahmeds tocilizumabinducedcytomegaloviruscolitisinapatientwithcovid19 AT aboukamarmohamadr tocilizumabinducedcytomegaloviruscolitisinapatientwithcovid19 AT sharafeldeanmouhammadz tocilizumabinducedcytomegaloviruscolitisinapatientwithcovid19 AT aldaraisehbashark tocilizumabinducedcytomegaloviruscolitisinapatientwithcovid19 AT nashwanabdulqadirj tocilizumabinducedcytomegaloviruscolitisinapatientwithcovid19 |